BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 10581194)

  • 1. A mutant streptokinase lacking the C-terminal 42 amino acids is less reactive with preexisting antibodies in patient sera.
    Torréns I; Ojalvo AG; Seralena A; Pupo E; Lugo V; Páez R
    Biochem Biophys Res Commun; 1999 Dec; 266(1):230-6. PubMed ID: 10581194
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A mutant streptokinase lacking the C-terminal 42 amino acids is less immunogenic.
    Torrèns I; Ojalvo AG; Seralena A; Hayes O; de la Fuente J
    Immunol Lett; 1999 Dec; 70(3):213-8. PubMed ID: 10656677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of circulating antibodies against a streptokinase C-terminal peptide in normal blood donors.
    Ojalvo AG; Pozo L; Labarta V; Torréns I
    Biochem Biophys Res Commun; 1999 Sep; 263(2):454-9. PubMed ID: 10491315
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mapping of the antigenic regions of streptokinase in humans after streptokinase therapy.
    Torréns I; Reyes O; Ojalvo AG; Seralena A; Chinea G; Cruz LJ; de la Fuente J
    Biochem Biophys Res Commun; 1999 May; 259(1):162-8. PubMed ID: 10334933
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparative study of the reactivity of natural and mutated streptokinase with total antistreptokinase antibodies in human sera.
    Bandehpour M; Sharifnia Z; Mohajeri N; Taherkhani M; Koochaki A; Yarian F; Seyyed N; Shirvani R; Pakzad P; Saadat H; Kazemi B
    Blood Coagul Fibrinolysis; 2012 Dec; 23(8):734-8. PubMed ID: 23080363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequences of antigenic epitopes of streptokinase identified via random peptide libraries displayed on phage.
    Parhami-Seren B; Keel T; Reed GL
    J Mol Biol; 1997 Aug; 271(3):333-41. PubMed ID: 9268662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and induction of circulating antibodies against recombinant staphylokinase.
    Declerck PJ; Vanderschueren S; Billiet J; Moreau H; Collen D
    Thromb Haemost; 1994 Jan; 71(1):129-33. PubMed ID: 8165631
    [TBL] [Abstract][Full Text] [Related]  

  • 8. T-ceIl recognition of discrete regions of the thrombolytic drug streptokinase.
    Lawley WJ; Fletcher S; Squire IB; Woods KL; Hewitt CR
    Clin Sci (Lond); 2000 Sep; 99(3):239-46. PubMed ID: 11787478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional roles of streptokinase C-terminal flexible peptide in active site formation and substrate recognition in plasminogen activation.
    Zhai P; Wakeham N; Loy JA; Zhang XC
    Biochemistry; 2003 Jan; 42(1):114-20. PubMed ID: 12515545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A functional analysis of the antigenicity of streptokinase using monoclonal antibody mapping and recombinant streptokinase fragments.
    Reed GL; Kussie P; Parhami-Seren B
    J Immunol; 1993 May; 150(10):4407-15. PubMed ID: 8482842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of the amino- and carboxyl-termini of streptokinase.
    Fay WP; Bokka LV
    Thromb Haemost; 1998 May; 79(5):985-91. PubMed ID: 9609234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of N-terminal domain of streptokinase in protein transport.
    Pratap J; Kaur J; RajaMohan G; Singh D; Dikshit KL
    Biochem Biophys Res Commun; 1996 Oct; 227(1):303-10. PubMed ID: 8858140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Profiling the immune responses of human patients treated with recombinant streptokinase after myocardial infarct.
    Reyes O; Torrens I; Ojalvo AG; Seralena A; Garay HE
    Mol Divers; 2004; 8(3):251-6. PubMed ID: 15384418
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anti-streptokinase antibodies].
    Helft G; Lecompte T; Le Feuvre C; Metzger JP; Vacheron A; Samama MM
    Arch Mal Coeur Vaiss; 1997 Jul; 90(7):975-80. PubMed ID: 9339259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mapping the antigenic regions of streptokinase in humans before and after streptokinase therapy.
    Parhami-Seren B; Lynch M; White HD; Reed GL
    Mol Immunol; 1995 Jul; 32(10):717-24. PubMed ID: 7659098
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the immunodominant regions of the Em18 antigen and improved serodiagnostic specificity for alveolar echinococcosis.
    Jiang L; Xu XN; Li X; Xue HC; Feng Z
    Parasite Immunol; 2004 Oct; 26(10):377-85. PubMed ID: 15752115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Anti-streptokinase titers and response to streptokinase treatment in Pakistani patients.
    Kazmi KA; Perwaiz Iqbal M; Rahbar A; Mehboobali N
    Int J Cardiol; 2002 Mar; 82(3):247-51. PubMed ID: 11911912
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased prevalence of transfusion-transmitted virus and cross-reactivity with immunodominant epitopes of the HRES-1/p28 endogenous retroviral autoantigen in patients with systemic lupus erythematosus.
    Gergely P; Pullmann R; Stancato C; Otvos L; Koncz A; Blazsek A; Poor G; Brown KE; Phillips PE; Perl A
    Clin Immunol; 2005 Aug; 116(2):124-34. PubMed ID: 15894513
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Borreliacidal OspC antibodies specific for a highly conserved epitope are immunodominant in human lyme disease and do not occur in mice or hamsters.
    Lovrich SD; Jobe DA; Schell RF; Callister SM
    Clin Diagn Lab Immunol; 2005 Jun; 12(6):746-51. PubMed ID: 15939749
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The primary GP5 neutralization epitope of North American isolates of porcine reproductive and respiratory syndrome virus.
    Plagemann PG
    Vet Immunol Immunopathol; 2004 Dec; 102(3):263-75. PubMed ID: 15507310
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.